My Portfolio

GoodRx Holdings Inc GDRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 4:42 PM EDT

2.81UNCH (UNCH)

Volume

13,951

2.81

-0.14 (-4.75%)

Volume

1,688,299

52 week range

1.77 - 5.81

Open2.95
Day High2.96
Day Low2.73
Prev Close2.95
52 Week High5.81
52 Week High Date10/09/25
52 Week Low1.77
52 Week Low Date03/02/26

Latest On GoodRx Holdings Inc

White House adds generic drugs to direct-to-consumer TrumpRx siteMay 18, 2026CNBC.com
Lightning Round: Buy ChevronMay 12, 2026CNBC.com
Eli Lilly launches program to boost employer coverage of obesity drugs in U.S.March 5, 2026CNBC.com
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a monthNovember 17, 2025CNBC.com
Healthy Returns: Amgen joins list of drugmakers selling directly to consumersOctober 7, 2025CNBC.com
Stocks making biggest moves midday: Meta Platforms, Duolingo, TeraWulf and more August 18, 2025CNBC.com
Lightning Round: Buy Dover right now, says Jim CramerJune 3, 2025CNBC.com

Key Stats

Market Cap951.678M
Shares Out338.68M
10 Day Average Volume1.79M
Dividend-
Dividend Yield-
Beta1.61

Latest On GoodRx Holdings Inc

White House adds generic drugs to direct-to-consumer TrumpRx siteMay 18, 2026CNBC.com
Lightning Round: Buy ChevronMay 12, 2026CNBC.com
Eli Lilly launches program to boost employer coverage of obesity drugs in U.S.March 5, 2026CNBC.com
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a monthNovember 17, 2025CNBC.com
Healthy Returns: Amgen joins list of drugmakers selling directly to consumersOctober 7, 2025CNBC.com
Stocks making biggest moves midday: Meta Platforms, Duolingo, TeraWulf and more August 18, 2025CNBC.com
Lightning Round: Buy Dover right now, says Jim CramerJune 3, 2025CNBC.com

KEY STATS

Open2.95
Day High2.96
Day Low2.73
Prev Close2.95
52 Week High5.81
52 Week High Date10/09/25
52 Week Low1.77
52 Week Low Date03/02/26
Market Cap951.678M
Shares Out338.68M
10 Day Average Volume1.79M
Dividend-
Dividend Yield-
Beta1.61

RATIOS/PROFITABILITY

EPS (TTM)0.10
P/E (TTM)29.27
Fwd P/E (NTM)8.57
EBITDA (TTM)183.582M
ROE (TTM)3.22%
Revenue (TTM)787.889M
Gross Margin (TTM)91.83%
Net Margin (TTM)2.61%
Debt To Equity (MRQ)78.37%

EVENTS

Earnings Date08/04/2026(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Content From Our Affiliates

Wells Fargo Remains a Buy on GoodRx Holdings (GDRX)June 2, 2026TipRanks
GoodRx launches GoodRX Companion, a new subscriptionMay 27, 2026TipRanks
Trump Trade: Trump announces expansion of TrumpRx.govMay 19, 2026TipRanks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Zoetis (ZTS), Sarepta Therapeutics (SRPT) and GoodRx Holdings (GDRX)May 15, 2026TipRanks
GoodRx price target raised to $4 from $3.50 at CitiMay 14, 2026TipRanks

Profile

GoodRx Holdings, Inc. is a platform for medication savings in the United States, used by consumers and healthcare professionals. The Company connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The Company's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions...

Trevor Bezdek

Non-Executive Co-Chairman of the Board

Wendy Barnes

President, Chief Executive Officer, Director

Christopher Mcginnis

Chief Financial Officer, Treasurer

Thomas Chan

Chief Accounting Officer

Address

2701 Olympic Boulevard

Santa Monica, CA

90404

United States

https://investors.goodrx.com/